Search results
Op-Ed: Overhyped Alzheimer's treatments betrayed patients' hopes. Here's how science should change
Los Angeles Times Opinion via Yahoo News· 2 years agoA researcher works with the medication aducanumab in Cambridge, Mass. in 2019. The drug received...
FDA Approves Lecanemab, a New Alzheimer’s Drug
Time via Yahoo News· 1 year agoCredit - Eisai Inc On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages....
Why It’s Hard to Get the New Alzheimer’s Drug Lecanemab
Time via Yahoo News· 1 year agoCredit - Eisai Inc. Alzheimer’s patients and their families welcomed the news on Jan. 6 that the...
New Alzheimer's drug slightly slows cognitive decline. Experts say it's not a silver bullet.
Live Science via Yahoo News· 1 year agoillustration depicts amyloid-beta peptides, the building blocks of amyloid-beta plaques, building up...
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
Salon via Yahoo News· 8 months agoMale figure walking through maze Getty Images/OsakaWayne Studios For decades, attempts to treat or...
Desperate for care: What we know as Alzheimer's groups ask for controversial drugs
The Tennessean via Yahoo News· 11 months agoAdvocates for Alzheimer's disease patients and their caregivers recently rallied in Nashville and...
A New Drug Could Slow Alzheimer’s Disease, Data Show
Time via Yahoo News· 1 year agoCredit - Ronnie Kaufman/Larry Hirshowitz/Blend Images LLC—Getty Images Over the past few years, Alzheimer’s patients and their caregivers have been on a...
FDA approves Relyvrio, the first new ALS drug in five years. Patients had wanted it sooner.
USA TODAY via Yahoo News· 2 years agoSOMERVILLE, Mass. — Bruce Rosenblum knows the drug Relyvrio won't save his life. It might not even...
A New Alzheimer's Drug Is One Step Closer to Full Approval. But Access Remains a Problem
Time via Yahoo News· 11 months agoCredit - Eisai Inc. A panel of experts who advise the U.S. Food and Drug Administration (FDA) agreed...
FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway
Benzinga via Yahoo Finance· 1 year agoThe FDA has approved Biogen Inc's (NASDAQ: BIIB) second Alzheimer's disease treatment, Leqembi...